Analysis of salivary alpha-L-fucosidase and salic acid among oral sub-mucous fibrosis patients.
alpha L fucosidase
salic acid
saliva
Journal
Bioinformation
ISSN: 0973-2063
Titre abrégé: Bioinformation
Pays: Singapore
ID NLM: 101258255
Informations de publication
Date de publication:
2024
2024
Historique:
received:
01
06
2024
revised:
30
06
2024
accepted:
30
06
2024
medline:
12
8
2024
pubmed:
12
8
2024
entrez:
12
8
2024
Statut:
epublish
Résumé
The salivary concentrations of alpha L fucosidase (AFU) and salic acid (SA) in oral submucous fibrosis patients and compare it with healthy controls is of interest to dentists. 40 patients of OSMF and 40 healthy controls were included. Estimation of AFU and SA in saliva and serum was carried out in every patient. The serum level of AFU was 37.4±26.8 in OSMF patients and saliva level of AFU was 35.4±14.5. The serum level of AFU was 19.2±4.3 in control group and saliva level of AFU was 35.4±14.5 in control group. The serum level of SA was 20.32±2.71 in OSMF patients and saliva level of SA was 18.21±2.40. The serum level of SA was 4.89 ±1.17 in control group and saliva level of SA was 3.13 ±1.04 in control group. Estimation of concentration of SA and AFU in saliva can be effective biomarker in diagnosis of OSMF.
Identifiants
pubmed: 39131533
doi: 10.6026/973206300200669
pii: 973206300200669
pmc: PMC11312311
doi:
Types de publication
Journal Article
Langues
eng
Pagination
669-673Informations de copyright
© 2024 Biomedical Informatics.